Cited by 496Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.

Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

Civeira, Fernando·2004·Atherosclerosis

DOI 10.1016/j.atherosclerosis.2003.11.010

Open this paper in CoChat — free account

Abstract

Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism characterized by very high plasma concentrations of low density lipoprotein cholesterol (LDLc), tendon xanthomas and increased risk of premature coronary heart disease (CHD). FH is a public health problem throughout the world. There are 10,000,000 people with FH worldwide, mainly heterozygotes, and approximately 85% of males and 50% of females with FH will suffer a coronary event before 65 years old if appropriate preventive efforts are not implemented. Early identification of persons with FH and their relatives, and the early start of treatment are essential issues in the prevention of premature cardiovascular disease (CVD) and death in this population. However, guidelines for the general population formally exclude FH from their diagnostic and treatment recommendations. These guidelines have been elaborated by a group of international experts with the intention to answer the main questions about heterozygous FH (heFH) subjects that physicians worldwide face in the diagnosis and management of these patients.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2003.11.010

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261

Show all 125 references

Research works printed but not linked: 2

Defesche J. Familial hypercholesterolemia. In: Betteridge J, editor. Lipids and vascular disease, vol. 6. London: Martin Dunitz; 2000. p. 65–76.
Mabuchi, 1989, Development of coronary heart disease in familial hypercholesterolemia, Circulation, 79, 225, 10.1161/01.CIR.79.2.225 · DOI

Sorted by citations

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M. C. D. O., Saraiva, J., Chacra, A., Bianco, H. T., Neto, A. A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A. C., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 690
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.001 · Cited by 622
Genetic identification of familial hypercholesterolemia within a single U.S. health care system
Abul-Husn, N. S., Manickam, K., Jones, L. K., Wright, E. A., Hartzel, D. N., Gonzaga-Jauregui, C., O’Dushlaine, C., Leader, J. B., Lester Kirchner, H., Lindbuchler, D. M., et al. (2016) · Science · doi:10.1126/science.aaf7000 · Cited by 425
Gut microbiota and cardiovascular disease: opportunities and challenges
Kazemian, N., Mahmoudi, M., Halperin, F. A., Wu, J. C., & Pakpour, S. (2020) · Microbiome · doi:10.1186/s40168-020-00821-0 · Cited by 404
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Watts, G. F., Gidding, S. S., Wierzbicki, A. S., Toth, P. P., Rodrigo Alonso, K., Brown, W. V., Bruckert, É., Defesche, J. C., Lin, K. K., Livingston, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.025 · Cited by 384
Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Hopkins, P. N., Toth, P. P., Ballantyne, C. M., & Rader, D. J. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.452 · Cited by 357
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
Grundy, S. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 353
Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
Akioyamen, L. E., Genest, J. J., Shan, S., Reel, R. L., Albaum, J. M., Chu, A., & Tu, J. V. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016461 · Cited by 366
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
Grundy, S. M., Arai, H., Barter, P. J., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A. M., Davidson, M. H., Genest, J. J., Kesäniemi, Y. A., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 334
International Journal of Collaborative Research on Internal Medicine & Public Health
Valdivia, J. R. M. (2021) · Journal of Womens Health Issues and Care · Cited by 300
Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands
Pijlman, A. H., Huijgen, R., Verhagen, S. N., Imholz, B. P. M., Liem, A. H., Kastelein, J. J. P., Abbink, E. J., Stalenhoef, A. F. H., & Visseren, F. L. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.014 · Cited by 238
Recommendations for the use of LDL apheresis
Thompson, G. R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.009 · Cited by 270
Diagnosis and treatment of familial hypercholesterolaemia
Hovingh, G. K., Davidson, M. H., Kastelein, J. J. P., & O’Connor, A. M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht015 · Cited by 265
Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy
McGowan, M. P., Tardif, J., Češka, R., Burgess, L. J., Soran, H., Gouni‐Berthold, I., Wagener, G., & Chasan-Taber, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049006 · Cited by 228
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
Harada‐Shiba, M., Arai, H., Ishigaki, Y., Ishibashi, S., Okamura, T., Ogura, M., Dobashi, K., Nohara, A., Bujo, H., Miyauchi, K., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.cr003 · Cited by 224
Disorders of lipid metabolism. Clinical Guidelines 2023
Владиславович, Е. М., Kukharchuk, V. V., Сергиенко, И. В., Alieva, A. S., Antsiferov, M. B., Ansheles, A. A., Arabidze, G. G., Dm, A., Arutyunov, G. P., Ахмеджанов, Н. М., et al. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5471 · Cited by 270
Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
Besseling, J., Kindt, I., Hof, M. H. P., Kastelein, J. J. P., Hutten, B. A., & Hovingh, G. K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.020 · Cited by 212
Familial hypercholesterolaemia: A model of care for Australasia
Watts, G. F., SULLIVAN, D. R., Poplawski, N. K., van Bockxmeer, F., Hamilton‐Craig, I. R., Clifton, P. M., O’Brien, R. C., Bishop, W., George, P. M., Barter, P. J., et al. (2011) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2011.06.001 · Cited by 206
Xanthomas: Clinical and pathophysiological relations
Žák, A., Zeman, M., Slaby, A., & Vecka, M. (2014) · Biomedical Papers · doi:10.5507/bp.2014.016 · Cited by 194
Comparison of Genetic Versus Clinical Diagnosis in Familial Hypercholesterolemia
Civeira, F., Ros, E., Jarauta, E., Plana, N., Zambón, D., Puzo, J., de Esteban, J. P. M., Ferrando, J., Zabala, S., Almagro, F., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.06.056 · Cited by 180
Self-citation
Guidelines for the Management of Familial Hypercholesterolemia
Harada‐Shiba, M., Arai, H., Oikawa, S., Ohta, T., Okada, T., Okamura, T., Nohara, A., Bujo, H., Yokote, K., Wakatsuki, A., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14621 · Cited by 175
Semi-supervised learning of the electronic health record for phenotype stratification
Beaulieu‐Jones, B. K., & Greene, C. S. (2016) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2016.10.007 · Cited by 175
Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Daniels, S. R., Gidding, S. S., & de Ferranti, S. D. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.453 · Cited by 173
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation
Watts, G. F., Gidding, S. S., Wierzbicki, A. S., Toth, P. P., Rodrigo Alonso, K., Brown, W. V., Bruckert, É., Defesche, J. C., Lin, K. K., Livingston, M., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.01.002 · Cited by 165
Universal Screening for Familial Hypercholesterolemia in Children
Klančar, G., Grošelj, U., Kovač, J., Bratanič, N., Bratina, N., Podkrajšek, K. T., & Battelino, T. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.017 · Cited by 152
Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology
Backer, G. D., Besseling, J., Chapman, J., Hovingh, G. K., Kastelein, J. J. P., Kotseva, K., Ray, K. K., Reiner, Ž., Wood, D., & Bacquer, D. D. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.809 · Cited by 151
Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors
Rodrigo Alonso, K., Mata, N., Castillo, S., Fuentes, F. J., Sáenz, P. L. R., Muñiz-Grijalvo, O., Galiana, J., Figueras, R., Díaz-Díaz, J. L., Enterría, P. G., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.024 · Cited by 151
SINGLE NUCLEOTIDE POLYMORPHISMS THAT INFLUENCE LIPID METABOLISM: Interaction with Dietary Factors
Corella, D., & Ordovás, J. M. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092656 · Cited by 151
Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia
Zambón, D., Quintana, M., Mata, P., Alonso, R., Benavent, J., Cruz-Sánchez, F., Gich, J., Pocoví, M., Civeira, F., Capurro, S., et al. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.08.015 · Cited by 125
Self-citation
Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization
Descamps, O. S., Tenoutasse, S., Stéphenne, X., Gies, I., Beauloye, V., Lebrethon, M.-C., de Beaufort, C. E., Waele, K. D., Scheen, A. J., Rietzschel, E. R., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.016 · Cited by 149
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes
Nanchen, D., Gencer, B., Auer, R., Räber, L., Stefanini, G. G., Klingenberg, R., Schmied, C. M., Cornuz, J., Müller, O., Vogt, P., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv289 · Cited by 147
Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome
Amor‐Salamanca, A., Castillo, S., González‐Vioque, E., Domínguez, F., Quintana, L., Lluís-Ganella, C., Escudier-Villa, J. M., Ortega, J., Lara‐Pezzi, E., Alonso‐Pulpón, L., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.009 · Cited by 150
Efficacy criteria and cholesterol targets for LDL apheresis
Thompson, G. R., Barbir, M., Davies, D., Dobral, P., Gesinde, M., Livingston, M., Mandry, P., Marais, A. D., Matthews, S. B., Neuwirth, C. K. Y., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.010 · Cited by 135
Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
Mata, N., Rodrigo Alonso, K., Badimón, L., Padró, T., Fuentes, F. J., Muñiz-Grijalvo, O., Pérez‐Jiménez, F., López‐Miranda, J., Díaz-Díaz, J. L., Vidal, J. I., et al. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-94 · Cited by 136
Animal Models of Calcific Aortic Valve Disease
Sider, K. L., Blaser, M. C., & Simmons, C. A. (2011) · International Journal of Inflammation · doi:10.4061/2011/364310 · Cited by 146
Phytosterols/Stanols Lower Cholesterol Concentrations in Familial Hypercholesterolemic Subjects: A Systematic Review with Meta-Analysis
Moruisi, K. G., Oosthuizen, W., & Opperman, A. M. (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719513 · Cited by 134
Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010
Mundal, L. J., Sarancic, M., Ose, L., Iversen, P. O., Borgan, J., Veierød, M. B., Leren, T. P., & Retterstøl, K. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001236 · Cited by 128
Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease
Yuan, G. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051313 · Cited by 126
Finding missed cases of familial hypercholesterolemia in health systems using machine learning
Banda, J. M., Sarraju, A., Abbasi, F., Parizo, J., Pariani, M., Ison, H., Briskin, E., Wand, H., Dubois, S., Jung, K., et al. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0101-5 · Cited by 123
Reliable Low-Density DNA Array Based on Allele-Specific Probes for Detection of 118 Mutations Causing Familial Hypercholesterolemia
Tejedor, D. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.045203 · Cited by 122
Tendon Xanthomas in Familial Hypercholesterolemia Are Associated With Cardiovascular Risk Independently of the Low-Density Lipoprotein Receptor Gene Mutation
Civeira, F., Castillo, S., Rodrigo Alonso, K., Meriño-Ibarra, E., Cenarro, A., Artied, M., Martín‐Fuentes, P., Ros, E., Pocovı́, M., & Mata, P. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000177811.14176.2b · Cited by 121
Self-citation
Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review
Grošelj, U., Kovač, J., Šuštar, U., Mlinarič, M., Fras, Z., Podkrajšek, K. T., & Battelino, T. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.858 · Cited by 123
Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
Vuorio, A. F., Watts, G. F., Schneider, W. J., Tsimikas, S., & Kovanen, P. T. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12981 · Cited by 122
Pregnancy Outcomes in Familial Hypercholesterolemia: A Registry-Based Study
Toleikyte, I., Retterstøl, K., Leren, T. P., & Iversen, P. O. (2011) · Circulation · doi:10.1161/circulationaha.110.990929 · Cited by 112
Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
Wang, A., Richhariya, A., Gandra, S. R., Calimlim, B., Kim, L., Quek, R. G. W., Nordyke, R. J., & Toth, P. P. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003294 · Cited by 110
Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis
Arambepola, C., Farmer, A. A., Perera, R., & Neil, H. A. W. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.030 · Cited by 109
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
Thompson, G. R., Catapano, A. L., Saheb, S., Atassi, M., Barbir, M., Eriksson, M., Paulweber, B., Sijbrands, E. J. G., Stalenhoef, A. F. H., & Parhofer, K. G. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283402f53 · Cited by 106
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
Kastelein, J. J. P., Robinson, J. G., Farnier, M., Krempf, M., Langslet, G., Lorenzato, C., Gipe, D. A., & Baccara‐Dinet, M. T. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6523-z · Cited by 102
Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study
Safarova, M. S., Liu, H., & Kullo, I. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.08.001 · Cited by 102
Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
Harada‐Shiba, M., Arai, H., Ohmura, H., Okazaki, H., Sugiyama, D., Tada, H., Dobashi, K., Matsuki, K., Minamino, T., Yamashita, S., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.cr005 · Cited by 105
The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes
Cenarro, A., Etxebarria, A., de Castro-Orós, I., Stef, M., Bea, A. M., Palacios, L., Mateo-Gallego, R., Benito-Vicente, A., Ostolaza, H., Tejedor, T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3874 · Cited by 100
Self-citation
Familial hypercholesterolemia: A review
Varghese, M. J. (2014) · Annals of Pediatric Cardiology · doi:10.4103/0974-2069.132478 · Cited by 98
Perceived Risk and Representations of Cardiovascular Disease and Preventive Behaviour in People Diagnosed with Familial Hypercholesterolemia
Claassen, L., Henneman, L., Kindt, I., Marteau, T. M., & Timmermans, D. R. M. (2010) · Journal of Health Psychology · doi:10.1177/1359105309345170 · Cited by 95
Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Neefjes, L. A., ten Kate, G. R., Rossi, A., Nieman, K., Galema-Boers, A. J., Langendonk, J. G., Weustink, A. C., Mollet, N. R., Sijbrands, E. J. G., Krestin, G. P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.052 · Cited by 95
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.
Gaddi, A. V., Cicero, A. F. G., Odoo, F. O., Poli, A. A., & Paoletti, R. (2007) · PubMed Central · Cited by 92
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Krogh, H. W., Mundal, L. J., Holven, K. B., & Retterstøl, K. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv602 · Cited by 91
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Watts, G. F., Gidding, S. S., Wierzbicki, A. S., Toth, P. P., Rodrigo Alonso, K., Brown, W. V., Bruckert, É., Defesche, J. C., Lin, K. K., Livingston, M., et al. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314533218 · Cited by 87
Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia
Miname, M. H., Ribeiro, M. S., Filho, J. P., Ávila, L. F., Bortolotto, L. A., Martinez, L. R. C., Rochitte, C. E., & Santos, R. D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.001 · Cited by 85
Current Role of Lipoprotein Apheresis
Thompson, G. R., & Parhofer, K. G. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0787-5 · Cited by 84
The Use of Achilles Tendon Sonography to Distinguish Familial Hypercholesterolemia from Other Genetic Dyslipidemias
Junyent, M., Gilabert, R., Zambón, D., Núñez, I., Vela, M., Civeira, F., Pocovı́, M., & Ros, E. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183888.48105.d1 · Cited by 83
Self-citation
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week multicenter, randomized, double-blind, controlled trial
Huijgen, R., Abbink, E. J., Bruckert, E., Stalenhoef, A. F. H., Imholz, B. P. M., Durrington, P. N., Trip, M. D., Eriksson, M., Visseren, F. L. J., Schaefer, J. R., et al. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.04.014 · Cited by 80
Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management
Najam, O., & Ray, K. K. (2015) · Cardiology and Therapy · doi:10.1007/s40119-015-0037-z · Cited by 84
Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry
Iyengar, S. S., Gupta, R., Ravi, S., Thangam, S., Alexander, T., Manjunath, C. N., Keshava, R., Patil, C., Sheela, A., & Sawhney, J. P. S. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.09.009 · Cited by 77
US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry
Ahmad, Z., Andersen, R. L., Andersen, L. H., O'Brien, E. C., Kindt, I., Shrader, P., Vasandani, C., Newman, C. B., deGoma, E. M., Baum, S. J., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.07.011 · Cited by 78
The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations
Civeira, F. (2010) · The Application of Clinical Genetics · doi:10.2147/tacg.s8285 · Cited by 75
Self-citation
A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia
Ademi, Z., Watts, G. F., Juniper, A., & Liew, D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.280 · Cited by 76
Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL
Artieda, M., Cenarro, A., Junquera, C., Lasierra, P., Martínez‐Lorenzo, M. J., Pocoví, M., & Civeira, F. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.087 · Cited by 73
Self-citation
Familial Hypercholesterolemia: An Under‐recognized but Significant Concern in Cardiology Practice
Foody, J. M. (2013) · Clinical Cardiology · doi:10.1002/clc.22223 · Cited by 73
The Type of LDLR Gene Mutation Predicts Cardiovascular Risk in Children with Familial Hypercholesterolemia
Guardamagna, O., Restagno, G., Rolfo, E., Pederiva, C., Martini, S., Abello, F., Baracco, V., Pisciotta, L., Pino, E., Calandra, S., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.02.022 · Cited by 72
Familial Hypercholesterolemia: The Lipids or the Genes?
Fahed, A. C., & Nemer, G. M. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-23 · Cited by 72
Familial hypercholesterolemia: current treatment and advances in management
Huijgen, R., Vissers, M. N., Defesche, J. C., Lansberg, P. J., Kastelein, J. J. P., & Hutten, B. A. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.4.567 · Cited by 71
Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects
Greyling, A., Witt, C. D., Oosthuizen, W., & Jerling, J. C. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061715 · Cited by 71
Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia
Harada-Shiba, M., Sugisawa, T., Makino, H., Abe, M., Tsushima, M., Yoshimasa, Y., Yamashita, T., Miyamoto, Y., Yamamoto, A., Tomoike, H., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4143 · Cited by 70
I Diretriz Brasileira de Hipercolesterolemia Familiar (HF)
Santos, R., Gagliardi, A., Xavier, H. T., Filho, A. C., Araújo, D., Cesena, F., Alves, R., Pereira, A., Lotemberg, A., Chacra, A., et al. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20120202 · Cited by 70
Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography
Li, J., Li, S., Zhu, C., Wu, N., Zhang, Y., Guo, Y., Gao, Y., Li, X., Qing, P., Cui, C.-J., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308456 · Cited by 69
Biliary Sterol Secretion Is Required for Functional In Vivo Reverse Cholesterol Transport in Mice
Nijstad, N., Gautier, T., Briand, F., Rader, D. J., & Tietge, U. J. F. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.055 · Cited by 69
Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia
Pérez‐Calahorra, S., Laclaustra, M., Marco-Benedí, V., Lamíquiz-Moneo, I., Pedro‐Botet, J., Plana, N., Sánchez-Hernández, R. M., Amor, A. J., Almagro, F., Fuentes, F. J., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.02.003 · Cited by 69
Self-citation
Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances
Stefanutti, C., & Thompson, G. R. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0465-6 · Cited by 66
Physical Activity and Atherosclerosis: Which Animal Model?
Turk, J. R., & Laughlin, M. H. (2004) · Canadian Journal of Applied Physiology · doi:10.1139/h04-042 · Cited by 69
No correlation and low agreement of imaging and inflammatory atherosclerosis’ markers in familial hypercholesterolemia
Martinez, L. R. C., Miname, M. H., Bortolotto, L. A., Chacra, A. P. M., Rochitte, C. E., Sposito, A. C., & Santos, R. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.014 · Cited by 65
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe
Ruel, I. L., Aljenedil, S., Sadri, I., de Varennes, É., Hegele, R. A., Couture, P., Bergeron, J., Wanneh, É., Baass, A. W., Dufour, R., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.279422 · Cited by 65
Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis
Kinnear, F. J., Wainwright, E. M., Perry, R. E., Lithander, F. E., Bayly, G. R., Huntley, A. L., Cox, J. S., Hamilton-Shield, J. P., & Searle, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030290 · Cited by 65
CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia
Neefjes, L. A., ten Kate, G. R., Rossi, A., Galema-Boers, A. J., Langendonk, J. G., Weustink, A. C., Moelker, A. D., Nieman, K., Mollet, N. R., Krestin, G. P., et al. (2011) · Heart · doi:10.1136/hrt.2010.220699 · Cited by 64
Statins and Pregnancy
Lecarpentier, É., Morel, O., Fournier, T., Éléfant, É., Chavatte‐Palmer, P., & Tsatsaris, V. (2012) · Drugs · doi:10.2165/11632010-000000000-00000 · Cited by 66
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
Nenseter, M. S., Krogh, H. W., Ueland, T., Langslet, G., Ose, L., Holven, K. B., & Retterstøl, K. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.007 · Cited by 62
Reducing the burden of disease and death from familial hypercholesterolemia: A call to action
Knowles, J. W., O'Brien, E. C., Greendale, K., Wilemon, K. A., Genest, J. J., Sperling, L. S., Neal, W. A., Rader, D. J., & Khoury, M. J. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.09.001 · Cited by 63
The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
Meshkov, A. N., Ershova, A. I., Kiseleva, A. V., Zotova, E. D., Сотникова, Е. А., Petukhova, A. V., Zharikova, A. A., Прокопьевич, М. П., Ta, R., Блохина, А. В., et al. (2021) · Genes · doi:10.3390/genes12010066 · Cited by 61
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing
Maglio, C., Mancina, R. M., Motta, B. M., Stef, M. A., Pirazzi, C., Palacios, L., Askaryar, N., Borén, J., Wiklund, O., & Romeo, S. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12263 · Cited by 61
Opportunistic screening for familial hypercholesterolaemia via a community laboratory
Bell, D. A., Hooper, A. J., Bender, R., McMahon, J., Edwards, G., BOCKXMEER, F. M. V., Watts, G. F., & Burnett, J. R. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012002 · Cited by 61
The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease
Thompson, G. R. (2013) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2012.10.001 · Cited by 59
Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort
Allard, M. D., Saeedi, R., Yousefi, M., & Frohlich, J. J. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-65 · Cited by 56
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Holven, K. B., Narverud, I., Krogh, H. W., Halvorsen, B. L., Langslet, G., Nenseter, M. S., Ulven, S. M., Ose, L., Aukrust, P., & Retterstøl, K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.022 · Cited by 55
Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso
Mata, P., Rodrigo Alonso, K., Ruiz, A., González‐Juanatey, J. R., Badimón, L., Díaz-Díaz, J. L., Múñoz, M. T., Muñiz-Grijalvo, O., Galve, E., Irigoyen, L., et al. (2014) · Atención Primaria · doi:10.1016/j.aprim.2013.12.015 · Cited by 54
Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants
Benito‐Vicente, A., Uribe, K. B., Jebari‐Benslaiman, S., Galicia-García, U., Ostolaza, H., & Martín, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061676 · Cited by 57
Management of Familial Hypercholesterolemia: Current Status and Future Perspectives
Lui, D. T. W., Lee, A. C. H., & Tan, K. C. B. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa122 · Cited by 63
Familial hypercholesterolemia: a missed opportunity in preventive medicine
Watts, G. F., Lewis, B., & SULLIVAN, D. R. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0941 · Cited by 53
Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care
Akyea, R. K., Qureshi, N., Kai, J., & Weng, S. F. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00349-5 · Cited by 55
A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia
Davidson, M. H. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.01.005 · Cited by 51
Universal screening for familial hypercholesterolemia in 2 populations
Šuštar, U., Kordonouri, O., Mlinarič, M., Kovač, J., Arens, S., Sedej, K., Bizjan, B. J., Podkrajšek, K. T., Danne, T., Battelino, T., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.06.010 · Cited by 50

Authors: Civeira, F.
Affiliations: Hospital Universitario Miguel Servet (ES)
Corresponding author: Civeira, Fernando
ORCID: Civeira, Fernando
Venue: Atherosclerosis
Publisher: Elsevier BV
Published: 2004-03
Volume: 173
Issue: 1
Pages: 55-68
ISSN: 0021-9150 (ISSN-L)
DOI: 10.1016/j.atherosclerosis.2003.11.010
OpenAlex: W2042489459
Cited by: 495
References: 125
Citations by year: 2026: 3 · 2025: 2 · 2024: 14 · 2023: 10 · 2022: 23 · 2021: 15 · 2020: 26 · 2019: 25 · 2018: 28 · 2017: 30 · 2016: 34 · 2015: 27 · 2014: 41 · 2013: 36 · 2012: 24
FWCI: 18.32
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Atherosclerosis (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: heterozygous familial hypercholesterolemia, LDL cholesterol, coronary artery disease, cardiovascular disease prevention, diagnosis, treatment, tendon xanthomas, lipoprotein metabolism
MeSH terms: Adult, Aged, Hypolipidemic Agents, Combined Modality Therapy, Diet, Female, Heterozygote, Humans, Hyperlipoproteinemia Type II, Life Style, Male, Middle Aged, Prognosis, Severity of Illness Index, Global Health, Survival Analysis, Age Distribution, Sex Distribution, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks